منابع مشابه
Acute neuromuscular respiratory paralysis.
This article reviews the recognition, diagnosis and management of respiratory failure in acute neuromuscular disease. Respiratory failure requiring artificial ventilation occurs in about 14% of patients with Guillain-Barre syndrome (GBS),' a small percentage of patients with myasthenia gravis and polymyositis, and also in acute rhabdomyolysis and a wide range of other less common disorders (tab...
متن کاملNeuromuscular disease causing acute respiratory failure.
In the developed world, Guillain-Barré syndrome and myasthenia gravis account for the majority of cases of acute respiratory failure associated with neuromuscular disease. The 4 components that contribute to respiratory failure are upper-airway dysfunction, inspiratory-muscle weakness, expiratory-muscle weakness, and the pulmonary complications associated with these conditions. Careful observat...
متن کاملCauses and outcomes of acute neuromuscular respiratory failure.
OBJECTIVE To identify the spectrum of causes, analyze the usefulness of diagnostic tests, and recognize prognostic factors in patients with acute neuromuscular respiratory failure. METHODS We evaluated 85 patients admitted to the intensive care unit (ICU) at Mayo Clinic, Rochester, between 2003 and 2009 with acute neuromuscular respiratory failure, defined as a need for mechanical ventilation...
متن کاملNeuromuscular disorders and acute respiratory failure: diagnosis and management.
Respiratory failure could result from a cardiopulmonary or a primary neurological disease. The latter could happen as a result of involvement of the central nervous system or a neuromuscular disease. Different neuromuscular diseases could result in respiratory failure by causing significant weakness of the respiratory and upper airways muscles. When confronted with a patient who presents with r...
متن کاملNeuromuscular blockers in early acute respiratory distress syndrome.
BACKGROUND In patients undergoing mechanical ventilation for the acute respiratory distress syndrome (ARDS), neuromuscular blocking agents may improve oxygenation and decrease ventilator-induced lung injury but may also cause muscle weakness. We evaluated clinical outcomes after 2 days of therapy with neuromuscular blocking agents in patients with early, severe ARDS. METHODS In this multicent...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology, Neurosurgery & Psychiatry
سال: 1994
ISSN: 0022-3050
DOI: 10.1136/jnnp.57.6.762-a